Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ketty Peris

Showing results (461-470 of 534) with videos related to

Pageof 54
Sort By:
Clinical and Experimental Dermatology|January 13, 2026
Long-Term Effectiveness of Bimekizumab in Plaque Psoriasis: Two-Year Drug Survival from a Real-Life Multicenter Italian StudyEleonora De Luca, Annunziata Dattola, Fabio Artosi, et al.
Dermatology Practical & Conceptual|May 22, 2025
Management of Local Skin Reactions Caused by 5-FU 4% Cream for the Treatment of Actinic Keratosis: A Delphi ConsensusGabriella Brancaccio, Giulia Briatico, Zoe Apalla, et al.
Cancers|May 13, 2023
Surgical Resection of Pulmonary Metastases from Melanoma in Oligometastatic Patients: Results from a Multicentric Study in the Era of Immunoncology and Targeted TherapyElisa Meacci, Dania Nachira, Maria Teresa Congedo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2022
Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant TreatmentClaus Garbe, Ulrike Keim, Teresa Amaral, et al.
Familial Cancer|July 3, 2021
Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone familyKevin M Brown, Mai Xu, Michael Sargen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 11, 2026
Dermatologic adverse events associated with amivantamab: A multicentre studyVasiliki Nikolaou, Ander Mayor, Vincent Sibaud, et al.
Frontiers in Public Health|September 2, 2024
Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian studyGiacomo Caldarola, Giulia Raimondi, Tonia Samela, et al.
Dermatology and Therapy|February 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE StudyEmanuele Trovato, Claudio Bonifati, Simone Ribero, et al.
Italian Journal of Dermatology and Venereology|March 9, 2022
Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasisPaolo Gisondi, Maria C Fargnoli, Paolo Amerio, et al.
Acta Dermato-Venereologica|April 27, 2021
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME StudyAntonio Costanzo, Filomena Russo, Marco Galluzzo, et al.
Pageof 54

Showing results (461-470 of 534) with videos related to

Sort By:
Pageof 54
Clinical and Experimental Dermatology|January 13, 2026
Long-Term Effectiveness of Bimekizumab in Plaque Psoriasis: Two-Year Drug Survival from a Real-Life Multicenter Italian StudyEleonora De Luca, Annunziata Dattola, Fabio Artosi, et al.
Dermatology Practical & Conceptual|May 22, 2025
Management of Local Skin Reactions Caused by 5-FU 4% Cream for the Treatment of Actinic Keratosis: A Delphi ConsensusGabriella Brancaccio, Giulia Briatico, Zoe Apalla, et al.
Cancers|May 13, 2023
Surgical Resection of Pulmonary Metastases from Melanoma in Oligometastatic Patients: Results from a Multicentric Study in the Era of Immunoncology and Targeted TherapyElisa Meacci, Dania Nachira, Maria Teresa Congedo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2022
Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant TreatmentClaus Garbe, Ulrike Keim, Teresa Amaral, et al.
Familial Cancer|July 3, 2021
Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone familyKevin M Brown, Mai Xu, Michael Sargen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 11, 2026
Dermatologic adverse events associated with amivantamab: A multicentre studyVasiliki Nikolaou, Ander Mayor, Vincent Sibaud, et al.
Frontiers in Public Health|September 2, 2024
Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian studyGiacomo Caldarola, Giulia Raimondi, Tonia Samela, et al.
Dermatology and Therapy|February 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE StudyEmanuele Trovato, Claudio Bonifati, Simone Ribero, et al.
Italian Journal of Dermatology and Venereology|March 9, 2022
Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasisPaolo Gisondi, Maria C Fargnoli, Paolo Amerio, et al.
Acta Dermato-Venereologica|April 27, 2021
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME StudyAntonio Costanzo, Filomena Russo, Marco Galluzzo, et al.
Pageof 54